• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Segment 5: Clinical Pathways - A Shared Decision-Making Tool?

Article

Have clinical pathways in oncology developed enough for providers and patients to use them as a shared decision-making tool? Panelists provide insight.

The panel then discussed their view on clinical pathways as a shared decision-making tool.

Blaise Polite, MD, MPP, said that they could be used in that capacity, “but they are not typically designed that well to open up in front of the patient.” He believes there are other, much better, tools for the process.

Michael Fisch, MD, MPH, agreed that clinical pathways are not intended to be a shared decision-making tool. While patients and their physicians make clinical decisions, pathways do not lead the discussion, he added.

Kathy Lokay concurred, saying that discussions on using pathways as a tool would really depend on the interest the patient might have in the process.

Related Videos
Video 2 - "Payer Needs and Strategies for Evaluating and Covering PDTs"
Video 1 - "Differentiating PDTs from Wellness Apps and Evaluating Efficacy"
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
ISPOR 2024 Recap
Chris Pagnani, MD, PC
Video 4 - "Oral SERDs in Development for ER+/HER2- Metastatic Breast Cancer"
Video 3 - "The Role of Oral SERDs in ER+/HER2- Metastatic Breast Cancer"
Screenshot of Stephen Freedland, MD, during a video interview
"Integrating New PAH Therapies into Clinical Practice"
"Clinical Evidence for Emerging PAH Therapies"
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.